How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,396 results for

Six Item Cognitive Impairment Test

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The Six-Item Cognitive Impairment Test Is Associated with Adverse Outcomes in Acutely Hospitalized Older Patients: A Prospective Cohort Study Full Text available with Trip Pro

The Six-Item Cognitive Impairment Test Is Associated with Adverse Outcomes in Acutely Hospitalized Older Patients: A Prospective Cohort Study The study aim was to investigate whether cognitive impairment, measured by the Six-Item Cognitive Impairment Test (6-CIT), is an independent predictor of adverse outcomes in acutely hospitalized older patients.This was a prospective multicenter study including acutely hospitalized patients aged 70 years and older. Multivariable logistic regression (...) was used to investigate whether impaired cognition (6-CIT ≥11 points) was an independent predictor of 90-day adverse outcome, a composite measure of functional decline and mortality. Secondary endpoints were hospital length of stay, new institutionalization, and in-hospital mortality.In total, 196 (15.6%) of 1,252 included patients had a 6-CIT ≥11. Median age was 80 years (interquartile range 74-85). Patients with impaired cognition had higher rates of 90-day adverse outcome (41.7% compared to 30.3

2018 Dementia and geriatric cognitive disorders extra

2. Six Item Cognitive Impairment Test

Six Item Cognitive Impairment Test Six Item Cognitive Impairment Test Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Six Item (...) Cognitive Impairment Test Six Item Cognitive Impairment Test Aka: Six Item Cognitive Impairment Test , 6CIT II. Indications screening in primary care III. Background Six question test can be completed within 4 minutes Formulated from a regression analysis of the Blessed Information Memory Concentration (BIMC) Kingshill Version 2000 Rights are owned by Kingshill Research Centre in Swindon, UK Medical providers are allowed free usage IV. Questions (correct answers are assigned 0 points) What year

2018 FP Notebook

3. Validity and Reliability of the 6-Item Cognitive Impairment Test for Screening Cognitive Impairment: A Review. Full Text available with Trip Pro

instruments and lack of consensus as to which screening tool is best. Cognitive tests with attention items may be particularly useful in acute settings, given the importance of delirium detection. However, it is crucial that cognitive screening instruments are fast and reliable.The Six-Item Cognitive Impairment Test (6-CIT) is a feasible instrument for cognitive screening among older adults attending a general practitioner or hospital. Although researchers have investigated its accuracy in diagnosing (...) Validity and Reliability of the 6-Item Cognitive Impairment Test for Screening Cognitive Impairment: A Review. A large proportion of older adults with dementia remain undiagnosed, presenting to hospital with occult dementia, and are at risk for adverse outcomes, especially delirium. Routine screening for cognitive impairment among older adult patients presenting to acute hospitals could help alleviate this problem; however, this is hampered by time constraints, poor knowledge of screening

2016 Dementia and Geriatric Cognitive Disorders

4. Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-Type Dementia

problem in longer studies. More work is needed to understand the relationship between intermediate outcomes such as cognitive test results and the onset of mild cognitive impairment and dementia. viii Contents Executive Summary ES-1 Chapter 1. Introduction 1 Background 1 Cognitive Impairment 1 Dementia—Definitions and Diagnotics 1 Age-Related Cognitive Decline and Mild Cognitive Inpairment—Definitions and Diagnostics Distinguishing Between Mild Cognitive Impairment and Dementia 2 Causes of Cognitive (...) Table 4A.6. Training interventions for older adults with normal cognition 26 Table 4A.7. Cognitive testing interventions for adults with mild cognitive impairment 31 Table 4A.8. Summary of overall results of cognitive training for older adults with normal cognition 36 Table 4A.9. Summary of overall results of cognitive training for cognitively impaired older adults 37 xii Table 4B.1. Conclusions: Physical activity versus inactive comparisons in adults with normal cognition 40 Table 4B.2. Results

2017 Effective Health Care Program (AHRQ)

5. Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-Type Dementia

problem in longer studies. More work is needed to understand the relationship between intermediate outcomes such as cognitive test results and the onset of mild cognitive impairment and dementia. viii Contents Executive Summary ES-1 Chapter 1. Introduction 1 Background 1 Cognitive Impairment 1 Dementia—Definitions and Diagnotics 1 Age-Related Cognitive Decline and Mild Cognitive Inpairment—Definitions and Diagnostics Distinguishing Between Mild Cognitive Impairment and Dementia 2 Causes of Cognitive (...) Table 4A.6. Training interventions for older adults with normal cognition 26 Table 4A.7. Cognitive testing interventions for adults with mild cognitive impairment 31 Table 4A.8. Summary of overall results of cognitive training for older adults with normal cognition 36 Table 4A.9. Summary of overall results of cognitive training for cognitively impaired older adults 37 xii Table 4B.1. Conclusions: Physical activity versus inactive comparisons in adults with normal cognition 40 Table 4B.2. Results

2017 Effective Health Care Program (AHRQ)

6. EANM-EAN recommendations for the use of brain 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in neurodegenerative cognitive impairment and dementia: Delphi consensus Full Text available with Trip Pro

. FDG‐PET to support the diagnosis of FTLD in MCI (PICO 2) Critical outcomes were not available in any of the examined papers, denoting lack of objective data on the possible incremental diagnostic value of FDG‐PET in this case. The consensual recommendation was defined in Delphi Round II, with six panellists deciding to recommend clinical use. Indeed, FTLD may be hard to recognize, especially in the prodromal stage where behavioural changes may mimic psychiatric disorders and cognitive impairment (...) EANM-EAN recommendations for the use of brain 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in neurodegenerative cognitive impairment and dementia: Delphi consensus European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus - Nobili - 2018 - European Journal of Neurology - Wiley Online Library Search

2018 European Academy of Neurology

7. The Erlangen test of activities of daily living in persons with mild dementia or mild cognitive impairment (ETAM) - an extended validation. Full Text available with Trip Pro

The Erlangen test of activities of daily living in persons with mild dementia or mild cognitive impairment (ETAM) - an extended validation. The ability to perform activities of daily living (ADLs) is a central marker in the diagnosis and progression of the dementia syndrome. ADLs can be identified as basic ADLs (BADLs), which are fairly easy to perform, or instrumental ADLs (IADLs), which involve more complex activities. Presently, the only performance-based assessment of IADL capabilities (...) in persons with cognitive impairment is the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM). The aim of the present study was to revalidate the ETAM in persons with mild cognitive impairment (MCI) or mild dementia and to analyze its application to persons with moderate dementia.We used baseline data from a cluster randomized controlled trial involving a sample of 443 users of 34 day-care centers in Germany. We analyzed groups of persons

2018 BMC Psychiatry Controlled trial quality: uncertain

8. Vital signs and impaired cognition in older emergency department patients: The APOP study. Full Text available with Trip Pro

of acute hemodynamic changes, and cognitive impairment in older ED patients.Prospective cohort study.ED's of two tertiary care and two secondary care hospitals in the Netherlands.2629 patients aged 70-years and older.Vital signs were measured at the moment of ED arrival as part of routine clinical care. Cognition was measured using the Six-Item Cognitive Impairment Test (6-CIT).The median age of patients was 78 years (IQR 74-84). Cognitive impairment was present in 738 patients (28.1%). When comparing (...) Vital signs and impaired cognition in older emergency department patients: The APOP study. Cognitive impairment is a frequent problem among older patients attending the Emergency Department (ED) and can be the result of pre-existing cognitive impairment, delirium, or neurologic disorders. Another cause can also be acute disturbance of brain perfusion and oxygenation, which may be reversed by optimal resuscitation. This study aimed to assess the relationship between vital signs, as a measure

2019 PLoS ONE

9. Six Item Cognitive Impairment Test

Six Item Cognitive Impairment Test Six Item Cognitive Impairment Test Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Six Item (...) Cognitive Impairment Test Six Item Cognitive Impairment Test Aka: Six Item Cognitive Impairment Test , 6CIT II. Indications screening in primary care III. Background Six question test can be completed within 4 minutes Formulated from a regression analysis of the Blessed Information Memory Concentration (BIMC) Kingshill Version 2000 Rights are owned by Kingshill Research Centre in Swindon, UK Medical providers are allowed free usage IV. Questions (correct answers are assigned 0 points) What year

2015 FP Notebook

10. The Effectiveness of Combining Physical Exercise and Cognitive Training for Individuals With Mild Cognitive Impairment

the mobility and dynamic balance ability. The participants will be required to stand up from a chair, walk 3 meters, turn around, then walk back to the chair, and sit down. The time to complete the TUG test has been shown to be a good indicator to detect potential fallers and frail elderly (Podsiadlo & Richardson, 1991). The test-retest reliability of TUG on individuals with cognitive impairment was excellent. Change scores of the Wechsler Memory Scale (WMS) [ Time Frame: baseline, posttest (an expected (...) average of 3 months) ] The CIQ measures items relevant to home integration, social integration, and productive activities. Change scores of the color trials test [ Time Frame: baseline, posttest (an expected average of 3 months) ] Assess executive function. Change scores of the Everyday Cognition scales (ECog)-12 items [ Time Frame: baseline, posttest (an expected average of 3 months) ] To detect cognitive and functional decline. The ECog shows promise as a useful tool for the measurement of general

2018 Clinical Trials

11. Comprehensive Cognitive Remediation as a Strategy to Prevent Cognitive Impairment Associated With Age and Disability With the REHACOP Program

. The outcome of visuo-constructive abilities was calculated of the total score of the drawing condition. The outcome of visual memory was calculated of the total score of the copy condition. Change from baseline performance on Clock Drawing Test (CDT) (Neuropsychological test) [ Time Frame: 3 months and 12 month follow-up ] Clock Drawing Test (CDT) is used for screening for cognitive impairment and dementia and as a measure of spatial dysfunction and neglect. This test includes 2 conditions (free drawing (...) Comprehensive Cognitive Remediation as a Strategy to Prevent Cognitive Impairment Associated With Age and Disability With the REHACOP Program Comprehensive Cognitive Remediation as a Strategy to Prevent Cognitive Impairment Associated With Age and Disability With the REHACOP Program - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2018 Clinical Trials

12. Screening Tools to Identify Adults with Cognitive Impairment Associated with Dementia

Impairment Associated with Dementia 9 Table 2: Summary of Included Studies First Author and Year Patient Population Index Test(s) Comparator(s) or Reference Standard Findings Wiechmann, 2010 52 Patients with VaD or AD N not reported in abstract CDT, four point scoring system Clinical diagnosis Good sensitivity and specificity for dementia, utility for discriminating between VaD and AD not supported. 3MS = modified Mini-Mental State Examination; 6CIT = Six Item Cognitive Impairment Test; 7MS = 7-Minutes (...) . PubMed: PM21923703 43. Chen MR, Guo QH, Cao XY, Hong Z, Liu XH. A preliminary study of the Six-Item Screener in detecting cognitive impairment. Neurosci Bull. 2010 Aug;26(4):317-21. PubMed: PM20651813 44. Clionsky MI, Clionsky E. Development and validation of the Memory Orientation Screening Test (MOST): A better screening test for dementia. Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):650-6. PubMed: PM21131671 45. Knopman DS, Roberts RO, Geda YE, Pankratz VS, Christianson TJ, Petersen RC, et al

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

13. Cognitive Impairment in Adults with Non−Central Nervous System Cancers (PDQ®): Health Professional Version

or the National Institutes of Health (NIH). General Information About Cognitive Impairment in Cancer Survivors Cancer survivors experience more-than-expected symptoms related to cognitive impairment.[ ] Formal neuropsychological testing demonstrates a range of objective cognitive deficits in some but not all survivors who report symptoms, compared with healthy controls; these deficits include faulty memory, deficits in concentration, decreased rates of information processing, and reduced executive function (...) .[ - ] Furthermore, subjective reports of cognitive impairment often do not correlate with the results of formal neuropsychological testing.[ , ] Finally, the risk factors for subjective or objective cognitive impairment—such as age, preexisting cognitive function, type of cancer, type of chemotherapy, and the natural history of the impairments—remain a matter of active investigation. The oncology clinician will care for survivors with objective or subjective cognitive impairment and is advised to consider

2017 PDQ - NCI's Comprehensive Cancer Database

14. Safety and quality issues associated with the care of patients with cognitive impairment in acute care settings

Assessment Method (CAM) is recommended for delirium screening in both ED and acute hospital wards. • The CAM-ICU is recommended for delirium screening in the intensive care unit (ICU). • The DRS-R-98 is recommended for the assessment of delirium in older patients following hip fracture. 5• Brief, validated tests (requiring five minutes or less) for the assessment of CI in older hospital patients include the 6-Item Cognitive Impairment Test (6CIT), Mini-Cog and Six- Item Screener (SIS). • One study showed (...) Safety and quality issues associated with the care of patients with cognitive impairment in acute care settings Evidence for the safety and quality issues associated with the care of patients with cognitive impairment in acute care settings: a rapid review October 2013 Suggested citation: Australian Commission on Safety and Quality in Health Care (2013). Evidence for the safety and quality issues associated with the care of patients with cognitive impairment in acute care settings: a rapid

2013 Sax Institute Evidence Check

15. Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus

Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus (ClearMEMory) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03527472 Recruitment Status : Recruiting First Posted : May 17

2018 Clinical Trials

16. Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease

Not Applicable Detailed Description: The overall purpose and objective of this project is to test the hypothesis that high intensity endurance exercise causes beneficial brain adaptation in patients with mild cognitive impairment in Parkinson's disease (PD-MCI). Aim 1 will determine the effect of high intensity endurance exercise on cognitive function and other clinical symptoms in PD-MCI. Aim 2 will determine the effect of high intensity endurance exercise on brain structure and function in PD-MCI. Aim 3 (...) generate within 60 seconds, the Category Verbal Fluency assesses the number of words within particular categories participants can generate within 60 seconds. Benton Judgement of Line Orientation Test [ Time Frame: Baseline and 6 Months ] Benton Judgment of Line Orientation Test is a standardized test with 30 items that is specific for visual spatial cognition. Tests will be administered at baseline, after 3, 6, 9 and 12 months of treatment. The minimum score is 0, indicating low visual spatial

2018 Clinical Trials

17. A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov

2018 Clinical Trials

18. Impact of Physical Activity in Vascular Cognitive Impairment ( AFIVASC )

in those subjects with previous stroke/TIA without criteria for vascular cognitive impairment no dementia. This cognitive criteria will be assessed by a clinical neurologist Cognitive Status measured by neuropsychological measures [ Time Frame: 1 year ] Change in neuropsychological evaluation (1.5 SD of initial medium score) for composite scores calculated by averaging all different domains of the tests applied or for global measures (MOCA). Secondary Outcome Measures : Impact of physical activity (...) (correlated with TIA clinical symptoms) in CT/MRI. Criteria B: No functional changes: IADL 0 (no item changed, or 1 single item with minimal change), according to the scoring methods of the LADIS study (minimum of 4 items applicable) or no cognitive changes regarding the suggested Montreal Cognitive Assessment Test (Moca) cut off point for dementia in clinical Portuguese samples (score < 17). Exclusion Criteria(Subjects cannot be included if they have at least one of the following): Diagnosis of dementia

2018 Clinical Trials

19. A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

, working memory, verbal learning, speed of processing, attention/vigilance, visual learning, social cognition, reasoning and problem solving). The MCCB neurocognitive composite score is a standardized mean of the six domain scores (excluding social cognition). Raw scores are converted to age and sex adjusted t-scores which are standardized to normative data, and have a mean of 50 and standard deviation of 10 in the general healthy population. A higher score indicates less impairment. Safety (...) A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information

2018 Clinical Trials

20. Efficacy Study of Yi-Zhi-An-Shen Granules For Older Adults With Amnestic Mild Cognitive Impairment

: Baseline, 8 weeks, 16 weeks, 10 months, 16 months, 22 months ] Changes in the global cognitive function will be accessed by MMSE to evaluate the severity of subjects' cognitive impairment. The MMSE includes orientation, registration, attention and calculation, recalling and language tests, for a total of 30 points. A score below 24 is considered abnormal for dementia screening. Change from Baseline in the Montreal Cognitive Assessment (MoCA) [ Time Frame: Baseline, 8 weeks, 16 weeks, 10 months, 16 (...) and related dementias: Memory, Orientation, Judgment and Problem Solving, Community Affairs, Home and Hobbies, and Personal Care. Scores on the CDR range from 0 (no impairment) to 3 (severe impairment). The total CDR ratings for each of the six cognitive/functional domains can be added to create a CDR sum of boxes (CDR-SB). Change from Baseline in the Activity of Daily Living (ADL) [ Time Frame: Baseline, 8 weeks, 16 weeks, 10 months, 16 months, 22 months ] ADLs will be assessed including basic activities

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>